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Abstract This review summarizes current concepts in the
diagnosis and management of the patients with eosino-
philic granuloma. Given the benign biology, the clinical
course, and the pediatric group of patients that this con-
dition more commonly affects, a treatment approach that
carries a lower risk of complications while ensuring a
successful cure is desirable. Variable treatment options
have been reported with satisfactory results and a recur-
rence rate of less than 20 %. In this setting, symptomatic
lesions that are accessible in the spine or the extremities
may be treated with intralesional methylprednisolone
injection after tissue biopsy for histological diagnosis.
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Introduction
Langerhans-cell histiocytosis is a rare disease involving
clonal proliferation of Langerhans cells [1, 2]. It is part of a
group of clinical syndromes called histiocytoses, which are
characterized by an abnormal proliferation of histiocytes
(an archaic term for activated dendritic cells and macro-
phages). These diseases are related to other forms of
abnormal proliferation of white blood cells, such as leu-
kemias and lymphomas. The disease, previously known as
histiocytosis X, was renamed in 1985 by the Histiocyte
Society as Langerhans-cell histiocytosis because of the
proliferation of Langerhans-cells. The spectrum includes
localized-to-bone eosinophilic granuloma, and the rare
multisystem syndromes Hand–Schu¨ller–Christian disease
and Abt–Letterer–Siwe disease; the manifestations range
from isolated bone lesions to multisystem disease [1, 2].
Eosinophilic granuloma of bone
Eosinophilic granuloma is a rare, benign tumor-like dis-
order characterized by clonal proliferation of antigen-pre-
senting mononuclear cells of dendritic origin known as
Langerhans cells [1, 2]. It is the most common manifes-
tation of Langerhans-cell histiocytosis (60–80 % cases),
accounting for less than 1 % of all bone tumors [3]. In
80 % of cases it affects children and adolescents [4, 5]. It
can affect any bone in the skeleton; however, bone lesions
are more common in the skull, mandible, spine, ribs, and
long bones; the femur, humerus and clavicle are the most
frequent sites [6]. The pathogenesis is unclear; viruses such
as Epstein-Barr and human herpes virus-6, bacteria, and
genetic factors have been implicated [3, 7, 8]. An
immunological dysfunction including an increase of certain
cytokines such as interleukin-1 and interleukin-10 in
affected patients has also been reported; familial occur-
rence is very rare [1, 9]. In the spine, eosinophilic granu-
loma accounts for 6.5–25 % of all spinal bone tumors
[5, 10–16]. The most common location is the thoracic spine
followed by the lumbar and the cervical spine
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[10, 15, 17–20]. Clinical symptoms are often severe and
depend on spinal location [14, 15, 20]. The most common
include back or neck pain, tenderness to spinal palpation
and restricted range of motion, or torticollis; spinal insta-
bility and neurological symptoms are uncommon
[5, 15, 21–25]. In the extremities, most lesions are dia-
physeal [7]. The physical examination of the child may be
essentially normal. Laboratory findings are usually non-
specific except for a moderate and inconsistent rise in
erythrocyte sedimentation rate.
Imaging
The typical radiographic appearance of eosinophilic gran-
uloma of the extremities is a punched-out lytic-bone lesion
without reactive sclerosis. In most cases, a hypervascular-
ized soft-tissue mass surrounds the affected bone [26, 27].
The radiographic differential diagnosis should include
plasmacytoma, multiple myeloma, osteochondritis, tuber-
culosis or osteomyelitis. In the spine, imaging studies may
reveal variable vertebral involvement, ranging from iso-
lated lytic lesions to a more significant vertebral collapse
that involves the pedicles and posterior vertebral elements
(vertebra plana), peridural spread and paraspinal soft tissue
components [20, 25]. Although eosinophilic granuloma is
the most common cause of vertebra plana, this finding can
also be found in Ewing’s sarcoma, lymphoma and other
sarcomas, infections such as tuberculosis, and osteogenesis
imperfect [28, 29]. In favor of the eosinophilic granuloma
are the isolated spinal disease, the lack of constitutional
symptoms, and minimal laboratory abnormalities [28].
Cervical spine eosinophilic granuloma more often mani-
fests with osteolytic lesions, rather than vertebra plana
[18, 20, 25, 30].
Diagnosis
Tissue biopsy for histological diagnosis is necessary when
clinical and radiological manifestations are ambiguous, and
the lesions are symptomatic [5]. CT-guided biopsy for
eosinophilic granuloma has been effective for histological
diagnosis, with low morbidity and a diagnostic accuracy of
70–100 % [5, 31–38]. Although anecdotally excellent
results with biopsy alone have been previously reported for
patients with eosinophilic granulomas [39], biopsy should
not be considered as a strategy for treatment of these
patients but rather as a step to confirm diagnosis
[26, 32, 33, 36–38, 40–42].
Management
Various treatment options have been reported for eosino-
philic granuloma of bone, including observation and
immobilization, indomethacin administration, methylpred-
nisolone injections, radiofrequency ablation, local excision
and curettage with or without bone grafting, chemotherapy
and irradiation; results have been reported as satisfactory
with a recurrence rate of less than 20 %
[11, 13, 14, 32–34, 43–48]. In general, the treatment of
typical solitary lesions in asymptomatic patients is con-
servative [16, 20, 25]. In patients with mild neurological
deficits from solitary eosinophilic granulomas of the spine,
immobilization and radiation therapy has been reported
[48]. Low-dose radiation therapy is advocated by some
authors to be effective in the healing of lytic lesions and
limiting disease progression [24]; others argue that radia-
tion therapy may damage endochondral growth plates and
limit bone healing and reconstitution [49, 50], or lead to
secondary radiation-induced morbidity such as post-radia-
tion sarcomas and myelitis [5, 51]. Although no clear
correlation between the degree of vertebral collapse and the
degree of neurological symptoms has been observed [25],
in patients with severe pain and restriction of range of
motion, and/or persistent spinal subluxation and neuro-
logical symptoms, surgical treatment is required
[12, 13, 15, 19, 20]. Chemotherapy is not recommended for
solitary eosinophilic granuloma, and should be reserved for
systemic involvement [13, 20, 48], or as initial therapy in
children with solitary lesions in locations that preclude safe
and complete surgical resection [52].
Since eosinophilic granuloma in children is known to
resolve spontaneously with time, observation alone or
biopsy alone to confirm the diagnosis have also been rec-
ommended as a treatment strategy [39]. A previous study
reported spontaneous resolution without recurrence of the
lesions in six skeletally immature patients that had biopsy
followed by observation alone (open biopsy in three and
percutaneous in three), suggesting the intriguing possibility
that surgery may result in a higher rate of recurrence than
less aggressive procedures [39]. We concur that biopsy
may have an effect on bone healing and eosinophilic
granuloma lesions reconstitution [39]. However, we dis-
agree that patients, especially children with symptomatic
bone lesions should be left alone to let the disease take its
natural course without a histological diagnosis. Moreover,
although solitary eosinophilic granuloma is considered a
benign lesion, without treatment, the time required for
resolution is unpredictable and can be associated with
significant morbidity secondary to unremitting pain,
restricted activity, growth disturbance, or pathological
fracture [26, 47]. Therefore, we recommend that these
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patients should undergo biopsy for histological diagnosis,
and treatment is then considered [36–38].
Methylprednisolone injection
Given the benign biology and clinical course of eosino-
philic granuloma and the pediatric group of patients that
this condition more commonly affects, a treatment
approach that carries a lower risk of complications while
ensuring a successful cure is desirable. In this setting,
symptomatic lesions that are accessible in the spine
(Figs. 1, 2, 3) or the extremities (Fig. 4) may be treated
with intralesional methylprednisolone injection after tissue
biopsy for histological diagnosis [8, 26, 31–33, 36–38].
Langerhans histiocytosis, as a systemic disease, appears
to be one of the most tissue-destructive syndromes, able to
induce multiple and grossly apparent lytic lesions
Fig. 1 a Sagittal T2-weighted MRI with fat suppression of the
cervical spine of a 43-year-old woman with a painful osteolytic lesion
of the C7 vertebral body. b CT-guided frozen section biopsy showed
eosinophilic granuloma; intralesional methylprednisolone injection
was performed. c Sagittal T2-weighted MRI with fat suppression.
d Axial CT scan show complete reconstitution of the lesion 4 years
after diagnosis and treatment
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involving many organs and the bones. Since this lytic
activity cannot be connected with a neoplastic nature of the
disease, one can reasonably assume that histiocytosis X
cells induce bone resorption in eosinophilic granuloma
through their ability to secrete locally tissue-lytic factors
such as interleukins and prostaglandins [53]. Several
in vitro studies have demonstrated the production of
interleukins (IL) such as IL-1 and prostaglandins (PG) such
as PGE2 and PGD2 by suspensions of Langerhans cells
[53, 54]. Although definitive proof that corticosteroid
injection is responsible for the observed response is diffi-
cult to obtain, the inhibition of IL-1-induced bone resorp-
tion and prostaglandin production by methylprednisolone
[55] may account for its clinical and radiographic effect.
Previous studies on the treatment of certain osteolytic
lesions including bone cysts, aneurysmal cysts, eosino-
philic granulomas and nonossifying fibromas showed that
the results obtained through the introduction of methyl-
prednisolone acetate in crystals were better than those
obtained by using other corticosteroids with topical action
[40]. This is because it is a microcrystalline suspension of
acetate of methylprednisolone that is relatively insoluble
and, therefore, has a prolonged pharmalogical effect [40].
A particular dosage for eosinophilic granulomas cannot be
recommended. The amount of methylprednisolone acetate
injected was established empirically on the basis of the size
of the lesion. A minimum of 40 mg for small lesions
involving less than half the diameter of the involved bone,
and up to 160 mg for large lesions of the pelvis has been
recommended [36–38].
Scaglietti et al. [40] first reported the use of intralesional
methylprednisolone injection for eosinophilic granuloma,
with excellent results, and recommended the injection of
methyl-prednisolone as the treatment of choice. Subse-
quently, similar clinical and radiographic results have been
described in case reports and small series of patients with
solitary and polyostotic lesions involving craniofacial and
long bones [27, 33, 56–58]. The benefit of intralesional
methylprednisolone injection compared with other methods
is that it promotes early relief of pain and pre-
dictable osseous healing [31, 34]. The results of treatment,
either as an adjunct or as primary treatment have been
comparable to other treatments [26, 31–33, 40]. Others
reported that intralesional methylprednisolone injection
adds little in children [33, 39]. However, in patients with
symptomatic lesions, treatment is required. In view of the
usually benign clinical course of the disease, in these
patients a simple, minimally invasive, outpatient treatment
Fig. 2 a Coronal CT scan of the cervical spine of a 5-year-old boy
with a painful osteolytic lesion of the C7 vertebral body. b CT-guided
frozen section biopsy showed eosinophilic granuloma; intralesional
methylprednisolone injection was performed. c, d Sagittal (c)and
axial (d) CT scans showing complete reconstitution of the lesion
5 years after diagnosis and treatment
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with a low rate of complications such as CT-guided
intralesional methylprednisolone injection may be consid-
ered the treatment of choice [36–38].
Complications such as femoral osteomyelitis [32] and
obstructive hydrocephalus have been reported after
methylprednisolone injections for eosinophilic granulomas
Fig. 3 a Lateral radiograph of the lumbar spine of a 6-year-old girl
with a painful osteolytic lesion of the L2 vertebral body with vertebral
plana deformity. CT-guided frozen section biopsy showed eosino-
philic granuloma; intralesional methylprednisolone injection was
performed. b Lateral radiograph of the lumbar spine shows complete
reconstitution of the lesion 7 years after diagnosis and treatment
Fig. 4 a Anteroposterior radiograph of the pelvis of a 6-year-old boy
with a painful osteolytic lesion at the left ischial ramus. CT-guided
frozen section biopsy showed eosinophilic granuloma; intralesional
methylprednisolone injection was performed. b Anteroposterior
radiograph of the pelvis shows complete reconstitution of the lesion
1 year after diagnosis and treatment
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[33]. However, in general, the morbidity associated with
the procedure has been negligible, even when relatively
inaccessible regions of the spine or pelvis are involved
[31]. The ability of the involved bone to reconstitute after
methylprednisolone injection is believed to be due to the
fact that the disease affects children before skeletal matu-
rity so that the pubertal growth spurt provides sufficient
time for adequate remodeling by the active growth plates
that are spared by the disease process [5, 34]. Some lesions
may fail to respond or are unsuitable for treatment by
injection because of their site, impending fracture, or soft-
tissue invasion [33]. Furthermore, it seems that incomplete
vertebral remodeling usually does not lead to chronic pain
or compromise structural integrity [5, 24, 59, 60].
Authors’ commentary and conclusion
This review summarizes current concepts in the diagnosis
and management of patients with eosinophilic granuloma,
with emphasis on the role of intralesional methylpred-
nisolone injection for the successful cure of patients with
symptomatic lesions. In the past, we planned for observa-
tion alone for patients with imaging evidence of eosino-
philic granuloma, and curettage for the most painful
lesions. It was our initial belief that percutaneous tech-
niques do not provide adequate tissue for definitive diag-
nosis for mesenchymal tumors [61–63]. This belief was
based on the agreement among pathologists that mes-
enchymal tumors are among the most difficult of patholo-
gies to accurately diagnose. We then realized that patients,
especially children with symptomatic bone lesions, should
not be left alone for the disease to take its natural course
without a histological diagnosis. Over the past 15 years, we
have been able to refine the procedures for needle or trocar
and frozen sections biopsy to assess the adequacy of the
biopsy specimen. Nowadays, we believe that histological
diagnosis is necessary for all bone lesions, and recommend
that biopsy should not be considered as a strategy for
treatment of eosinophilic granuloma but rather as a step to
confirm diagnosis. By using CT-guided intralesional
methylprednisolone injection, frozen sections histological
diagnosis can be obtained in all patients. After biopsy,
intralesional injection of methylprednisolone is considered
beneficial [31–33], or at least not harmful. In our practice,
tissue procurement and frozen sections biopsy are usually
diagnostic in all patients with suspected eosinophilic
granuloma. Even if the definite histological diagnosis is
different, intralesional methylprednisolone injection would
not have resulted in any adverse effect, but rather it would
have decreased intralesional edema and provided pain
relief. Our long-term results, (mean follow up, 9 years;
range, 4–23 years) support biopsy and intralesional
methylprednisolone injection as a safe treatment for eosi-
nophilic granulomas of bone with complete resolution of
pain and imaging reconstitution of the lesions.
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